Mar 24, 2021 by James Halley3 Healthcare Stocks That Could Be Millionaire-MakersWith solid revenue growth, these stocks have the potential to more than triple over the next few years.
Mar 22, 2021 by James HalleyThis High-Yield Dividend Stock Might Be in TroubleThe GEO Group's share price has tumbled over the past 12 months, and it may have further to fall.
Mar 18, 2021 by James HalleyCould DermTech Be a Millionaire-Maker Stock?There are lots of reasons to be excited about DermTech's breakthrough diagnostic technology.
Mar 13, 2021 by James Halley2 Pot Stocks to Buy in 2021 That Could Make You RichInnovative Industrial Properties, a cannabis REIT, and multiple-state cannabis operator Columbia Care are expected to have big revenue gains this year.
Mar 13, 2021 by James HalleyShould You Buy Cresco Labs in March?The cannabis company rewarded investors last year. Is there more gas left in the stock's tank?
Mar 13, 2021 by James HalleyCould Clover Health Be a Millionaire-Maker Stock?There's been a lot of bad news lately for the Medicare insurer, but looking at the company's financials, could it still be a stock that richly rewards investors?
Mar 9, 2021 by James Halley3 Monster Stocks in the MakingThese three stocks have plenty of momentum and solid financials, making them great long-term investments.
Mar 8, 2021 by James HalleyShould You Buy Ocugen Stock in March?Ocugen has set record highs this month on news regarding COVID-19 vaccine Covaxin. Is it too late to get in on the stock?
Mar 6, 2021 by James Halley3 Pet Med Companies Whose Growth Makes Them a Breed ApartThe pandemic puppy boom is real, and so are sales for these three pet stocks.
Mar 4, 2021 by James HalleyIs Green Thumb Industries a Buy?Green Thumb Industries, one of the biggest marijuana stocks by market cap, is finally turning a profit.
Mar 4, 2021 by James HalleyShould You Buy Invitae Stock?The past 12 months have been a wild ride for the genetic testing company's stock, with a sub-$10 low and a high of more than $60.
Mar 2, 2021 by James HalleyBetter Buy: CRISPR vs. Fulgent GeneticsThese stocks made investors a lot of money in 2020. Which one will be the better choice this year?
Feb 27, 2021 by James HalleyBetter Buy: Veeva Systems or Teladoc?Both tech-related medical stocks have had a phenomenal past 12 months, with shares rising more than 90%. But only one has a solid chance to continue that level of growth in 2021.
Feb 24, 2021 by James Halley3 High-Yield Stocks at Rock-Bottom PricesThere's no hiding that high-yield stocks can also bring high risk. These three stocks, however, offer high yields at a discount with relatively low risk.
Feb 23, 2021 by James Halley3 Stocks That Pay You Each MonthThere are plenty of stocks that will pay you a dividend each month. The trick is finding the right ones at the right time.
Feb 23, 2021 by James HalleyWhere Will Biogen Be in 5 Years?The biotech has a lot riding on whether the FDA approves its potential Alzheimer's treatment, aducanumab.
Feb 17, 2021 by James HalleyWhere Will Editas Medicine Be in 5 Years?In a field that's becoming more crowded, what will set Editas apart?
Feb 17, 2021 by James HalleyLike Dividends? I Bet You'll Love These 3 StocksThese three dividend stocks combine steady growth with solid dividend payouts.
Feb 11, 2021 by James HalleyThe 3 Best Marijuana Stocks to Buy Right NowIf you're looking for cannabis-related investments for 2021, these companies are already profitable -- and poised to grow.
Feb 10, 2021 by James HalleyWhy I'm Never Selling My Square StockSquare is a classic growth company that's constantly innovating and finding new sources of revenue, making it a keeper.